admin

Palantir Technologies (NYSE:PLTR) hasn’t fully recovered since pulling back with the overall market in late September. But PLTR stock has still managed to slowly move higher in recent weeks. Source: Ascannio / Shutterstock.com To some extent, this uptrend makes sense. After all, the “story” behind this stock remains intact. The company has continued to post strong
0 Comments
It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates.  According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
0 Comments
In this article MAXR A close look at the primary mirror of a Worldview Legion satellite during assembly and inspection. Maxar Maxar Technologies‘ stock jumped on Thursday after reporting third-quarter results, with Wall Street analysts welcoming the space company’s progress toward the launch of key satellites next year. The company reported an adjusted EBITDA profit
0 Comments
Key Takeaways Berkshire Hathaway beat analysts’ expectations on earnings and revenues but missed on operating earnings. Gains on its investment portfolio were down YOY, but operating earnings from all segments except insurance were up. Insurance posted a larger underwriting loss than in Q3 2020. Revenues increased YOY across business segments, reflecting the conglomerate’s broad exposure
0 Comments
If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency
0 Comments